Trends in the use of neoadjuvant chemotherapy for low-grade serous ovarian cancer in the United States. Silberman JN, Bercow AS, Gockley AA, Eisenhauer EL, et al. Gynecol Oncol 2023;175:60-65.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Silberman JN, Bercow AS, Gockley AA, Eisenhauer EL, et al. Trends in the use of neoadjuvant chemotherapy for low-grade serous ovarian cancer in the United States. Gynecol Oncol 2023;175:60-65.
PMID: 37327540